ENDRA Life Sciences Inc. (NDRA): Total Liabilities
$1.59M
As of 2025-12-31
$1.63M
As of 2026-06-30
-8.3%
3-year compound annual growth
0.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.59M | -15.8% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.89M | +72.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $1.10M | -47.1% | 2025-04-07, Balance as of period end |
| 2022-12-31 | $2.07M | -1.0% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $2.09M | +31.0% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $1.60M | -33.9% | 2021-03-25, Balance as of period end |
| 2019-12-31 | $2.42M | +147.9% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $974.6K | +14.9% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $848.2K | -38.7% | 2019-03-11, Balance as of period end |
| 2016-12-31 | $1.38M | n/a | 2018-03-20, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | 2025-12-31 | $1.59M | -15.8% |
| Positron Corp (POSC) | 2025-12-31 | $2.56M | +4.0% |
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $887.3K | +62.3% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $3.08M | +4.4% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.49M | +4.6% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.00M | +11.7% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $1.26M | -13.8% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $969.8K | +80.1% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $7.33M | +17.0% |
Compare NDRA, POSC, NXL, ESMC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗